Robert J. Cardnell

1.8k total citations
15 papers, 601 citations indexed

About

Robert J. Cardnell is a scholar working on Oncology, Molecular Biology and Electrical and Electronic Engineering. According to data from OpenAlex, Robert J. Cardnell has authored 15 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Electrical and Electronic Engineering. Recurrent topics in Robert J. Cardnell's work include Lung Cancer Research Studies (9 papers), PARP inhibition in cancer therapy (4 papers) and Cancer therapeutics and mechanisms (3 papers). Robert J. Cardnell is often cited by papers focused on Lung Cancer Research Studies (9 papers), PARP inhibition in cancer therapy (4 papers) and Cancer therapeutics and mechanisms (3 papers). Robert J. Cardnell collaborates with scholars based in United States, Brazil and Italy. Robert J. Cardnell's co-authors include Lauren A. Byers, Jing Wang, Lixia Diao, John V. Heymach, Ignacio I. Wistuba, John N. Weinstein, William N. William, Pan Tong, Edwin R. Parra and Kevin R. Coombes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Genetics.

In The Last Decade

Robert J. Cardnell

15 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Cardnell United States 7 400 311 149 112 112 15 601
Oriol Arpí Spain 15 376 0.9× 359 1.2× 149 1.0× 126 1.1× 86 0.8× 24 710
Lorenzo Castagnoli Italy 17 406 1.0× 368 1.2× 169 1.1× 105 0.9× 127 1.1× 31 726
Valentina E. Schneeberger United States 8 612 1.5× 587 1.9× 124 0.8× 143 1.3× 81 0.7× 11 862
Emanuela Balladore Italy 8 405 1.0× 272 0.9× 132 0.9× 67 0.6× 173 1.5× 14 771
David Molkentine United States 16 357 0.9× 371 1.2× 125 0.8× 186 1.7× 84 0.8× 30 708
Emily Tarco United States 14 346 0.9× 332 1.1× 149 1.0× 113 1.0× 29 0.3× 19 620
Jorge D. Gallo United States 10 337 0.8× 355 1.1× 75 0.5× 127 1.1× 37 0.3× 23 558
Andrew Elliott United States 10 260 0.7× 191 0.6× 89 0.6× 146 1.3× 54 0.5× 99 483
Lotte Hiddingh United States 8 203 0.5× 214 0.7× 109 0.7× 88 0.8× 139 1.2× 9 523
Montserrat Arumí-Uría Spain 9 235 0.6× 252 0.8× 101 0.7× 82 0.7× 29 0.3× 13 498

Countries citing papers authored by Robert J. Cardnell

Since Specialization
Citations

This map shows the geographic impact of Robert J. Cardnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Cardnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Cardnell more than expected).

Fields of papers citing papers by Robert J. Cardnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Cardnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Cardnell. The network helps show where Robert J. Cardnell may publish in the future.

Co-authorship network of co-authors of Robert J. Cardnell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Cardnell. A scholar is included among the top collaborators of Robert J. Cardnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Cardnell. Robert J. Cardnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhang, Bingnan, Kavya Ramkumar, Robert J. Cardnell, et al.. (2021). A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers. British Journal of Cancer. 125(10). 1333–1340. 37 indexed citations
2.
Zhang, Bingnan, C. Allison Stewart, Carl M. Gay, et al.. (2021). Abstract 384: Detection of DNA replication blocker SLFN11 in tumor tissue and circulating tumor cells to predict platinum response in small cell lung cancer. Cancer Research. 81(13_Supplement). 384–384. 6 indexed citations
3.
Cargill, Kasey R., C. Allison Stewart, Elizabeth M. Park, et al.. (2021). Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer. SHILAP Revista de lepidopterología. 9(1). 33–33. 41 indexed citations
4.
Ramkumar, Kavya, C. Allison Stewart, Carl M. Gay, et al.. (2020). 1736P Elevated AXL expression following SARS-CoV-2 infection in non-small cell lung cancer. Annals of Oncology. 31. S1015–S1016. 2 indexed citations
5.
Salvo, Gloria, Preetha Ramalingam, Natacha Phoolcharoen, et al.. (2020). PARP and PD-L1 as Potential Therapeutic Targets for Women with Neuroendocrine Cervical Cancer. Gynecologic Oncology. 156(3). e21–e22. 1 indexed citations
6.
Corte, Carminia Maria Della, Robert J. Cardnell, Li Shen, et al.. (2019). Activity of the novel Aurora kinase B inhibitor AZD2811 in biomarker-defined models of small cell lung cancer. Annals of Oncology. 30. v716–v716. 4 indexed citations
7.
Corte, Carminia Maria Della, Robert J. Cardnell, Carl M. Gay, et al.. (2019). Abstract B064: The Aurora kinase A-inhibitor, alisertib, is a potential candidate for combination with immunotherapy in small cell lung cancer. Molecular Cancer Therapeutics. 18(12_Supplement). B064–B064. 2 indexed citations
8.
Gay, Carl M., Pan Tong, Robert J. Cardnell, et al.. (2018). Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers. Clinical Cancer Research. 25(1). 346–357. 12 indexed citations
9.
Ferrarotto, Renata, Robert J. Cardnell, Shirley Y. Su, et al.. (2018). Poly ADP‐ribose polymerase‐1 as a potential therapeutic target in Merkel cell carcinoma. Head & Neck. 40(8). 1676–1684. 9 indexed citations
10.
Cardnell, Robert J., et al.. (2015). Abstract 7: PARP and Bcl-2 co-inhibition in small cell lung cancer (SCLC). Cancer Research. 75(15_Supplement). 7–7. 3 indexed citations
11.
Mak, Milena Perez, Pan Tong, Lixia Diao, et al.. (2015). A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition. Clinical Cancer Research. 22(3). 609–620. 348 indexed citations
12.
Valliani, Aly, Triparna Sen, Lixia Diao, et al.. (2015). Abstract 5316: Check point kinase 1 (Chk1) targeting as a novel therapeutic strategy in small cell lung cancer (SCLC). Cancer Research. 75(15_Supplement). 5316–5316. 1 indexed citations
13.
14.
Cardnell, Robert J., Ying Feng, Lixia Diao, et al.. (2013). Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer. Clinical Cancer Research. 19(22). 6322–6328. 131 indexed citations
15.
Cardnell, Robert J., et al.. (2006). In Vivo Analysis of a Gain-of-Function Mutation in the Drosophila eag-Encoded K+ Channel. Genetics. 172(4). 2351–2358. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oriol Arpí Breakdown of academic impact, for papers by Lorenzo Castagnoli Breakdown of academic impact, for papers by Valentina E. Schneeberger Breakdown of academic impact, for papers by Emanuela Balladore Breakdown of academic impact, for papers by David Molkentine Breakdown of academic impact, for papers by Emily Tarco Breakdown of academic impact, for papers by Jorge D. Gallo Breakdown of academic impact, for papers by Andrew Elliott Breakdown of academic impact, for papers by Lotte Hiddingh Breakdown of academic impact, for papers by Montserrat Arumí-Uría
Rankless by CCL
2026